SPOTLIGHT: Regeneron wins FDA approval


The FDA has approved Regeneron's Arcalyst for two rare inflammatory diseases. The ailments are known as cryopyrin-associated periodic syndromes, which can cause pain, fever and hearing loss. Some 300 people in the U.S. suffer from these conditions. Release